Scroll Top

Recent Top Projects

We are honored to have been entrusted with vital leadership roles that have had significant impact on the boards and businesses they serve, with a representative list below.
Recent Projects and Leadership Roles

We are honored to have been entrusted with vital leadership roles that have had significant impact on the boards and businesses they serve, with a representative list below.

FEATURED PLACEMENTS
Cardiff Oncology

Independent Director (2)

Alexion

Chief Medical Officer

3T Biosciences

Head of Finance

Carina Biotech

Independent Director (2)

Alovant

President and Chief Operating Officer

Accent Therapeutics

Head of Biology

Cardiff Oncology Independent Director (2)
Carina Biotech Independent Director (2)
Fate Therapeutics Independent Director
Histogen Independent Director (2)
Illumina Independent Director (3)
Ethics Advisory Board
Mammogen Independent Director
Pliant Therapeutics Independent Director (2)
SioGene Therapies Independent Director
Vaxxinity Independent Director
Alexion Chief Medical Officer
Alovant President and Chief Operating Officer
Ascensia Chief Medical Officer
Aviwell Chief Executive Officer & Director
Bexion Pharmaceuticals Chief Executive Officer & Director
Chief Financial Officer
BioLA Chief Executive Officer
Brickell Biotech Chief Medical Officer
Cardiff Oncology Chief Scientific Officer
Cellectis Chief Medical Officer
Cellics Chief Executive Officer & Director
Confidential Chief Financial Officer
Corsair Chief Executive Officer
Critical Path Institute Chief Executive Officer & Director
Dermavant Sciences Chief Scientific Officer
Engrail CSO and SVP of Development
Exciva Chief Executive Officer & Director
Fate Therapeutics Chief Medical Officer
Gallant Chief Executive Officer & Director
Glenmark Chief Commercial Officer
Halozyme Chief Operations Officer
Imagion Chief Development Officer
Inivata, Inc. Chief Medical Officer
LabCentral Chief People Officer
Lineage Cell Therapeutics Chief Executive Officer & Director
Mammogen Chief Executive Officer & Director
Neuraptive Chief Operating Officer and EVP, Head of R&D
New Rhein Managing Partner & Chief Medical Officer
Onchilles Chief Scientific Officer
Pierian Chief Executive Officer & Director
Poseida President, Gene Therapy
President, Cell Therapy
Sanofi Chief Patient Officer
Symbio Pharmaceuticals Chief Executive Officer
United Bomedical EVP, Research & Development
United Neuroscience Chief Scientific Officer
Valavant Chief Executive Officer & Director
3T Biosciences Head of Finance
Accent Therapeutics Head of Biology
Adaptimmune VP, Clinical Development
Advaxis VP, Medical
Alexion SVP, Medical Affairs
Country Leader
VP, Clinical Development Neurology,br>
VP, Quality Operations
Almatica VP, Regulatory Affairs
Amicus SVP, Clinical Research, Gene Therapy
Global Head of Medical Affairs
Ascensia Global Head, Clinical Development & Operations
Atyr VP, Regulatory Affairs
Bayer Healthcare Therapeutic Head, Cardiovascular
Head of Development Center, Skincare
Country Head France, BAH
Pricing Market Access EU
Becton Dickinson VP, Medical Affairs (4)
Beigene SVP, Global Head Business Development
VP, Alliance Project
VP, Global Clinical Operations
VP, Head of Europe Medical Affairs,br>
VP, Head of Late Stage Development
Blueprint Medicines VP, Biology
VP, Translational Medicine
Cardiff Oncology Inc. SVP, Regulatory Affairs
Cellectis SVP, Regulatory Affairs
Clovis VP, Safety & Pharmacovigilance
Embecta (subsidiary of BD) Global Head Medical,
Clinical and Scientific Affairs & Chief Medical Officer
EyePoint Pharmaceuticals Senior VP, Program Leadership
Fate Therapeutics SVP, Corporate Development
SVP, Technical Operations
VP, Clinical Development (3)
VP, Solid Tumor Biology
Glenmark VP, Market Access
Humacyte Inc. VP, Scientific & Medical Communications
Idorsia Clinical Lead – Neurology
Insmed SVP, Head of Clinical Development
Intellectual Ventures Commercial Lead, Medical Technologies
Intercept VP, Regulatory Affairs, R&D
Jasper Therapeutics VP, Clinical Operations
Johnson & Johnson VP, Biologics Discovery
Head, J&J Innovation West NA, Australia & New Zealand
LabCentral Executive Director, Ignite
Myovant SVP, Pharma. Operations and Development
Nutrinia VP, Regulatory Affairs
Pfizer VP, Development Head
Immuno-Oncology Medicine Team Lead
Pharma Essentia Global Head of Pharmacovigilance
Regeneron Global Program Head – Oncology
VP, Strategic Program Direction TA Head, Oncology
VP, Global Program Head Immunology
Strategic Program Director, CV/META
Strategic Program Heads (2)
Regulus VP, Preclinical Development
Sanofi Head of Bioprocesses
Symbio Pharmaceuticals SVP R&D and Global Chief Medical Officer
Talis BioMedical VP, Assay Development
Urovant VP, Manufacturing
VP, Regulatory Affairs & Quality Assurance VP, Manufacturing
Urovant VP, Manufacturing
Zymeworks SVP, Research

Section 1

Empty section. Edit page to add content here.

Section 2

Empty section. Edit page to add content here.

Alexion Chief Medical Officer
Alovant President and Chief Operating Officer
Ascensia Chief Medical Officer
Aviwell Chief Executive Officer & Director
Bexion Pharmaceuticals Chief Executive Officer & Director
Chief Financial Officer
BioLA Chief Executive Officer
Brickell Biotech Chief Medical Officer
Cardiff Oncology Chief Scientific Officer
Cellectis Chief Medical Officer
Cellics Chief Executive Officer & Director
Confidential Chief Financial Officer
Corsair Chief Executive Officer
Critical Path Institute Chief Executive Officer & Director
Dermavant Sciences Chief Scientific Officer
Engrail CSO and SVP of Development
Exciva Chief Executive Officer & Director
Fate Therapeutics Chief Medical Officer
Gallant Chief Executive Officer & Director
Glenmark Chief Commercial Officer
Halozyme Chief Operations Officer
Imagion Chief Development Officer
Inivata, Inc. Chief Medical Officer
LabCentral Chief People Officer
Lineage Cell Therapeutics Chief Executive Officer & Director
Mammogen Chief Executive Officer & Director
Neuraptive Chief Operating Officer and EVP, Head of R&D
New Rhein Managing Partner & Chief Medical Officer
Onchilles Chief Scientific Officer
Pierian Chief Executive Officer & Director
Poseida President, Gene Therapy
President, Cell Therapy
Sanofi Chief Patient Officer
Symbio Pharmaceuticals Chief Executive Officer
United Bomedical EVP, Research & Development
United Neuroscience Chief Scientific Officer
Valavant Chief Executive Officer & Director

Cardiff Oncology Independent Director (2)
Carina Biotech Independent Director (2)
Fate Therapeutics Independent Director
Histogen Independent Director (2)
Illumina Independent Director (3)
Ethics Advisory Board
Mammogen Independent Director
Pliant Therapeutics Independent Director (2)
SioGene Therapies Independent Director
Vaxxinity Independent Director

3T Biosciences Head of Finance
Accent Therapeutics Head of Biology
Adaptimmune VP, Clinical Development
Advaxis VP, Medical
Alexion SVP, Medical Affairs
Country Leader
VP, Clinical Development Neurology,br>
VP, Quality Operations
Almatica VP, Regulatory Affairs
Amicus SVP, Clinical Research, Gene Therapy
Global Head of Medical Affairs
Ascensia Global Head, Clinical Development & Operations
Atyr VP, Regulatory Affairs
Bayer Healthcare Therapeutic Head, Cardiovascular
Head of Development Center, Skincare
Country Head France, BAH
Pricing Market Access EU
Becton Dickinson VP, Medical Affairs (4)
Beigene SVP, Global Head Business Development
VP, Alliance Project
VP, Global Clinical Operations
VP, Head of Europe Medical Affairs,br>
VP, Head of Late Stage Development
Blueprint Medicines VP, Biology
VP, Translational Medicine
Cardiff Oncology Inc. SVP, Regulatory Affairs
Cellectis SVP, Regulatory Affairs
Clovis VP, Safety & Pharmacovigilance
Embecta (subsidiary of BD) Global Head Medical,
Clinical and Scientific Affairs & Chief Medical Officer
EyePoint Pharmaceuticals Senior VP, Program Leadership
Fate Therapeutics SVP, Corporate Development
SVP, Technical Operations
VP, Clinical Development (3)
VP, Solid Tumor Biology
Glenmark VP, Market Access
Humacyte Inc. VP, Scientific & Medical Communications
Idorsia Clinical Lead – Neurology
Insmed SVP, Head of Clinical Development
Intellectual Ventures Commercial Lead, Medical Technologies
Intercept VP, Regulatory Affairs, R&D
Jasper Therapeutics VP, Clinical Operations
Johnson & Johnson VP, Biologics Discovery
Head, J&J Innovation West NA, Australia & New Zealand
LabCentral Executive Director, Ignite
Myovant SVP, Pharma. Operations and Development
Nutrinia VP, Regulatory Affairs
Pfizer VP, Development Head
Immuno-Oncology Medicine Team Lead
Pharma Essentia Global Head of Pharmacovigilance
Regeneron Global Program Head – Oncology
VP, Strategic Program Direction TA Head, Oncology
VP, Global Program Head Immunology
Strategic Program Director, CV/META
Strategic Program Heads (2)
Regulus VP, Preclinical Development
Sanofi Head of Bioprocesses
Symbio Pharmaceuticals SVP R&D and Global Chief Medical Officer
Talis BioMedical VP, Assay Development
Urovant VP, Manufacturing
VP, Regulatory Affairs & Quality Assurance VP, Manufacturing
Urovant VP, Manufacturing
Zymeworks SVP, Research

CONTACT US

We make life-changing placements so our clients can change lives!®